Results 151 to 160 of about 4,350,325 (326)

Identification of bloodmeal sources of triatomines captured in the Paraguayan Chaco region of South America by means of molecular biology analysis [PDF]

, 2020
Stefanía Fraenkel, Oscar Daniel Salvioni Recalde, Antonieta Rojas de Árias, Verónica Paola Arze, Míriam Rolón, Natalia A. Ramírez, Celeste Vega Gómez   +6 more
openalex   +1 more source

Systems biology-guided identification of synthetic lethal gene pairs and its potential use to discover antibiotic combinations [PDF]

, 2015
Ramy K. Aziz, Jonathan M. Monk, Robert M. Lewis, Suh In Loh, Arti Mishra, Amrita Abhay Nagle, Chitkala Satyanarayana, Saravanakumar Dhakshinamoorthy, Michele Luche, Douglas B. Kitchen, Kathleen A. Andrews, Nicole L. Fong, Howard J. Li, Bernhard Ø. Palsson, Pep Charusanti   +14 more
openalex   +1 more source

Cloud Services for Patient Cohort Identification Using the Informatics for Integrating Biology and the Bedside Platform [PDF]

, 2020
Kavishwar B. Wagholikar, Shreekanth Joshi, Vishal V. Pai Vernekar, Yuri Ostrovsky, Somnath D. Desai, Pooja B. Magdum, Sachin B. Wakle, Sheetal Jain, Akshay Zagade, Rahul A. Patel, Shawn N. Murphy   +10 more
openalex   +1 more source

Identification of Reference Genes for Reverse Transcription-Quantitative PCR Analysis of Ginger Under Abiotic Stress and for Postharvest Biology Studies [PDF]

, 2022
Gang Li, Jiawei Ma, Junliang Yin, Fengling Guo, Keyong Xi, Peihua Yang, Xiaodong Cai, Qie Jia, Lu Li, Yiqing Liu, Yongxing Zhu   +10 more
openalex   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease [PDF]

, 2022
Jolien Perneel, Rosa Rademakers
openalex   +1 more source

Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours?

Molecular Oncology, EarlyView.
Current anticancer therapies are limited by the occurrence of resistance and undruggability of most proteins. Targeted protein degraders are novel, promising agents that trigger the selective degradation of previously undruggable proteins through the recruitment of the ubiquitin–proteasome machinery. Their mechanism of action raises exciting challenges,
Noé Herbel, Sophie Postel‐Vinay
wiley   +1 more source

Urban Ants of North America and Europe: Identification, Biology, and Management ‐ Edited by John Klotz, Laurel Hansen, Reiner Pospischil and Michael Rust

, 2009
Andrea Lucky
openalex   +1 more source

Identification of Therapeutic Covariant MicroRNA Clusters in Hypoxia-Treated Cardiac Progenitor Cell Exosomes Using Systems Biology

Circulation Research, 2015
W. Gray, Kristin M. French, Shohini K Ghosh-Choudhary, J. Maxwell, Milton E Brown, M. Platt, C. Searles, Michael E. Davis   +7 more
semanticscholar   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source